Chinese students always question why they are always asked if they have ever gotten Malaria before they purchase OPT insurance (aka opt保险) and/or H-1B insurance (aka h1b 保险), knowing that their medical insurance in the United States (aka 美国医疗保险) do not have malaria vaccination. However, if they know the spread ability and infectibility of malaria, their doubts will be easily cleaned up.

Malaria has inflicted tens of thousands of cases bodily injuries in the last century. Scientists and medical experts have been quarreled on the topic of whether or not the artemisinin fights against malaria best. This dispute was given a period with the Nobel Laureate Prize given to Tu Youyou, who made great contribution to human society in light of her and her team proposed solutions to the problem of artemisinin resistance. Admittedly, the proposal ignited malaria patients to live strong; the malaria vaccination has not been drafted in health insurance for OPT (aka opt期间保险) so far.

Artemisinin and its derivatives are known for their ability to swiftly reduce the number of parasites in the blood of patients with malaria and have saved millions of lives worldwide. The World Health Organization (WHO) recommends Artemisinin Combination Treatments (ACTs) as the first- and second-line treatment for malaria, which inflicts over 400,000 deaths every year worldwide. Here is an anecdote. The artemisinin resistance was formerly verified in the Greater Mekong river basins. During the Vietnam War, a large throne of American soldiers was infected with malaria and passed away. Survivals staying in Vietnam married local women. Years later, family of these survivals visited them in this Southeast nation. However, they were infected as well. They did not have American visitor insurance (aka 美国 探亲保险), and the local poor medical environment pushed many soldiers and their families to escape.

Tu said that treatment failures with ACTs are often directly attributed to the partner drug, which can be addressed by replacing the partner drug. For example, mefloquine plus artesunate can be switched to DHA with piperaquine if the former fails to deliver positive results. Artemisinin substances are extracted from Qinghao, a kind of Chinese medicinal herb which has been used for more than 2,000 years in China for treating infectious diseases. Tu’s solution provides new evidence that artemisinin is still “the best weapon” against malaria.

Since 2017, no malaria cases have been reported in China, indicating that the epidemic has been eradicated in the country. Yet many U.S. schools still ask Chinese students to report if they have ever been infected with malaria and to purchase required international student medical insurance (aka 留学生 医疗保险). China has continued to carry out research on malaria control and prevention and develop artemisinin-based antimalarial drugs for the fight against the disease globally. “Global malaria control is in line with the thrust of the Chinese government’s initiative to build a community with a shared future for humanity,” said Alonso. “The antimalarial research work carried out by Tu Youyou’s team is groundbreaking, outstanding and immeasurable.”